BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16584389)

  • 1. Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosis.
    Dilger K; Cascorbi I; Grünhage F; Hohenester S; Sauerbruch T; Beuers U
    Liver Int; 2006 Apr; 26(3):285-90. PubMed ID: 16584389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamic action of budesonide in early- and late-stage primary biliary cirrhosis.
    Hempfling W; Grunhage F; Dilger K; Reichel C; Beuers U; Sauerbruch T
    Hepatology; 2003 Jul; 38(1):196-202. PubMed ID: 12830002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
    Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P
    Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis.
    Dilger K; Denk A; Heeg MH; Beuers U
    Hepatology; 2005 Mar; 41(3):595-602. PubMed ID: 15726657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.
    Pauli-Magnus C; Feiner J; Brett C; Lin E; Kroetz DL
    Clin Pharmacol Ther; 2003 Nov; 74(5):487-98. PubMed ID: 14586389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis.
    Kimura Y; Selmi C; Leung PS; Mao TK; Schauer J; Watnik M; Kuriyama S; Nishioka M; Ansari AA; Coppel RL; Invernizzi P; Podda M; Gershwin ME
    Hepatology; 2005 Jan; 41(1):55-63. PubMed ID: 15690482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.
    Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN; Yu QZ
    Respiration; 2008; 75(4):380-5. PubMed ID: 17851225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance and prevalence of polymorphisms in CYP3A5 and MDR1 genes that encode tacrolimus biotransformation enzymes in liver transplant recipients.
    Barrera-Pulido L; Aguilera-García I; Docobo-Pérez F; Alamo-Martínez JM; Pareja-Ciuró F; Nuñez-Roldán A; Gómez-Bravo MA; Bernardos-Rodríguez A
    Transplant Proc; 2008 Nov; 40(9):2949-51. PubMed ID: 19010156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
    Siegmund W; Ludwig K; Giessmann T; Dazert P; Schroeder E; Sperker B; Warzok R; Kroemer HK; Cascorbi I
    Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.
    Johne A; Köpke K; Gerloff T; Mai I; Rietbrock S; Meisel C; Hoffmeyer S; Kerb R; Fromm MF; Brinkmann U; Eichelbaum M; Brockmöller J; Cascorbi I; Roots I
    Clin Pharmacol Ther; 2002 Nov; 72(5):584-94. PubMed ID: 12426522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
    Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
    Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of CYP3A5 and MDR1 genetic polymorphisms on urinary 6 beta-hydroxycortisol/cortisol ratio after grapefruit juice intake in healthy Chinese.
    Li D; Abudula A; Abulahake M; Zhu AP; Lou YQ; Zhang GL
    J Clin Pharmacol; 2010 Jul; 50(7):775-84. PubMed ID: 20160155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
    Meisel P; Giebel J; Kunert-Keil C; Dazert P; Kroemer HK; Kocher T
    Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-drug resistance gene-1 (MDR-1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements.
    Fredericks S; Jorga A; MacPhee IA; Reboux S; Shiferaw E; Moreton M; Carter ND; Holt DW; Johnston A
    Clin Transplant; 2007; 21(2):252-7. PubMed ID: 17425754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells.
    Calado RT; Falcão RP; Garcia AB; Gabellini SM; Zago MA; Franco RF
    Haematologica; 2002 Jun; 87(6):564-8. PubMed ID: 12031911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT; Lou HX; Zhao Y; Chin YM; Vathsala A
    Transplant Proc; 2008 Jun; 40(5):1690-5. PubMed ID: 18589174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.